GPP
COLL icon

Great Point Partners’s Collegium Pharmaceutical COLL Stock Holding History

Great Point Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-121,342
Closed -$2.4M – 39
2021
Q3 		$2.4M Sell
121,342
-740,068
-86% -$16M 0.56% 33
2021
Q2 		$20.4M Hold
861,410
– – 4.27% 7
2021
Q1 		$20.4M Buy
861,410
+440,027
+104% +$10.5M 4.22% 12
2020
Q4 		$8.44M Buy
+421,383
New +$8.23M 1.37% 24

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Great Point Partners's COLL Position: Q4 2021 in Review

Great Point Partners sold out of Collegium Pharmaceutical (COLL) in Q4 2021, closing a stake of 121,342 shares — an estimated $2.4M sold.

Great Point Partners first reported a position in COLL in Q4 2020 and held it in 4 quarters. The position peaked at $20.4M in Q1 2021. 159 funds tracked by Wall St. Rank hold COLL as of Q4 2021.

  • Great Point Partners reported no remaining Collegium Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Great Point Partners sold 121,342 Collegium Pharmaceutical shares in Q4 2021, an estimated $2.4M.
  • Great Point Partners first reported a position in Collegium Pharmaceutical in Q4 2020 and held it in 4 quarters.
  • Great Point Partners's Collegium Pharmaceutical position peaked at $20.4M in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2021.

Based on Great Point Partners's 13F filing for Q4 2021, filed 14 Feb 2022.